Showing results (111-120 of 146) with videos related to
Sort By:
Pageof 15
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Immediate side effects of stereotactic radiotherapy and radiosurgeryM Werner-Wasik, S Rudoler, P E Preston, et al.Cancer|July 15, 1995
Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02C B Scott, J S Nelson, N C Farnan, et al.International Journal of Radiation Oncology, Biology, Physics|May 20, 1993
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trialsJ R Simpson, J Horton, C Scott, et al.International Journal of Radiation Oncology, Biology, Physics|August 3, 2001
Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institutionD W Andrews, O Suarez, H W Goldman, et al.Journal of the National Cancer Institute|February 1, 1995
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancerW T Sause, C Scott, S Taylor, et al.Clinical Lung Cancer|January 15, 2004
Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapyM Werner-Wasik, R S Axelrod, D P Friedland, et al.The Cancer Journal From Scientific American|March 1, 1996
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiationC J Langer, W J Curran, S M Keller, et al.International Journal of Radiation Oncology, Biology, Physics|January 11, 1992
Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?W J Curran, S H Herbert, P M Stafford, et al.Clinical Lung Cancer|December 9, 2003
Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim reportB Movsas, R S Hudes, J Schol, et al.Cancer|August 11, 1991
Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11W J Curran, J D Cox, N Azarnia, et al.Pageof 15